BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 6338896)

  • 21. Identification of two major B cell forms of nodular mixed lymphoma.
    Grogan TM; Hicks MJ; Jolley CS; Rangel CS; Jones SE
    Lab Invest; 1984 Nov; 51(5):504-14. PubMed ID: 6387274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic expression of T lymphocytes in thymus and peripheral lymphoid tissues.
    Hsu SM; Jaffe ES
    Am J Pathol; 1985 Oct; 121(1):69-78. PubMed ID: 3931482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunoperoxidase study of normal and pathologic lymphoid tissue. Value of monoclonal antibodies].
    Delsol G; Al Saati T; Caveriviere P; Voigt JJ; Ancelin E; Rigal-Huguet F
    Ann Pathol; 1984; 4(3):165-83. PubMed ID: 6383412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies. Follicular and diffuse lymphomas of small-cleaved-cell type are related but distinct entities.
    Harris NL; Nadler LM; Bhan AK
    Am J Pathol; 1984 Nov; 117(2):262-72. PubMed ID: 6437232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of T-cell subsets identified by monoclonal antibodies in cell suspensions from lymph node biopsies of human B-cell lymphomas.
    Kvaløy S; Marton PF; Høst H; Solheim BG; Godal T
    Scand J Haematol; 1982 Apr; 28(4):293-305. PubMed ID: 6981200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibody studies in non-Hodgkin's lymphoma.
    Aisenberg AC; Wilkes BM; Harris NL
    Blood; 1983 Mar; 61(3):469-75. PubMed ID: 6824784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of histologic and immunologic heterogeneity of non-Hodgkin's lymphomas.
    Borowitz MJ; Croker BP; Metzgar RS
    Am J Pathol; 1981 Nov; 105(2):97-106. PubMed ID: 6170233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphoid leukemia and non-Hodgkin's lymphoma type continuum, superimposed to lymphocyte differentiation step continuum. A proposition for a revised W. H. O. lympiioid leukemia-lymphoma categorisation.
    Mathé G
    Biomed Pharmacother; 1985; 39(3):109-14. PubMed ID: 3864494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood and lymph node T-lymphocyte subsets in non-Hodgkin lymphomas.
    Lindemalm C; Mellstedt H; Biberfeld P; Björkholm M; Christensson B; Holm G; Johansson B; Sundblad R
    Scand J Haematol; 1983 Jan; 30(1):68-78. PubMed ID: 6601285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-lymphocyte subpopulations in B-cell-derived non-Hodgkin's lymphomas and Hodgkin's disease.
    Knowles DM; Halper JP; Jakobiec FA
    Cancer; 1984 Aug; 54(4):644-51. PubMed ID: 6234982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An immunocytochemical study of T-cell lymphomas using monoclonal and polyclonal antibodies effective in routinely fixed wax embedded tissues.
    Norton AJ; Isaacson PG
    Histopathology; 1986 Dec; 10(12):1243-60. PubMed ID: 3546052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relevance of 3A1 monoclonal antibody in the diagnosis of T-cell acute lymphoblastic leukemia.
    Lopez M; De Rossi G; Bonomo G; Napolitano M; Pasqualetti D; Guglielmi C; Annino L; Pandolfi F
    Diagn Immunol; 1985; 3(1):11-4. PubMed ID: 3873317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of antigens defined by OKB monoclonal antibodies on benign and malignant lymphoid cells and on nonlymphoid tissues.
    Knowles DM; Tolidjian B; Marboe CC; Mittler RS; Talle MA; Goldstein G
    Blood; 1984 Apr; 63(4):886-96. PubMed ID: 6423012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies of immunologic markers in malignant lymphomas: diagnostic and prognostic relevance].
    Huber H; Thaler J; Greil R; Gattringer C; Radaszkiewicz T
    Onkologie; 1986 Apr; 9(2):108-13. PubMed ID: 3520418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Ia-like antigen in lymphatic leukaemias and non-hodgkin lymphomas in correlation with other surface markers.
    Bergmann L; Mitrou PS; Cherdron T; Holloway K; Jost J; Timm V; Zerth G
    Scand J Haematol; 1982 Sep; 29(3):224-34. PubMed ID: 6983113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue.
    Norton AJ; Isaacson PG
    Am J Pathol; 1987 Aug; 128(2):225-40. PubMed ID: 3113255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cell population of cutaneous B-cell lymphomas.
    Willemze R; de Graaff-Reitsma CB; van Vloten WA; Meijer CJ
    Br J Dermatol; 1983 Apr; 108(4):395-409. PubMed ID: 6601490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
    Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
    Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Leu-8 surface antigen in B-cell lymphomas. Correlation with other B-cell markers.
    Carbone A; Manconi R; Poletti A; Gloghini A; De Paoli P; Volpe R
    J Pathol; 1988 Feb; 154(2):133-40. PubMed ID: 3258374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of B-cell non-Hodgkin's lymphomas. A study using a panel of monoclonal and heterologous antibodies.
    van der Valk P; Jansen J; Daha MR; Meijer CJ
    Virchows Arch A Pathol Anat Histopathol; 1983; 401(3):289-305. PubMed ID: 6195805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.